Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cristina Rodriguez-Padilla, Ph.D.
Universidad Autonoma de Nuevo Leon
Study Director - Jose Manuel Vazquez-Guillen, Ph.D.
Universidad Autonoma de Nuevo Leon
Principal InvestigatorKOL profile → - Rene Rodriguez-Gutierrez, Ph.D.
Universidad Autonoma de Nuevo Leon
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario "dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo Leon
Monterrey, Nuevo León, Mexico
- Laboratorio de Inmunologia Y Virologia
San Nicolás de los Garza, Nuevo León, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2021
- Primary completion
- 3 Feb 2022
- Completion
- 5 Mar 2022
- Last update posted
- 8 Nov 2024
- Registered enrollment
- 80
- Registry id
- NCT06676709
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.